Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients-Reference-Cited by-同舟云学术

Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients

Published:2000-12 Issue:18 Volume:14 Page:2869-2876
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Zhou Xiao-Jian,Havlir Diane V.,Richman Douglas D.,Acosta Edward P.,Hirsch Martin,Collier Ann C.,Tebas Pablo,Sommadossi Jean-Pierre

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference26 articles.

1. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

2. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

3. A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral Therapy

4. Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy

5. Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Les xénobiotiques dans le liquide cérébrospinal;Revue Francophone des Laboratoires;2023-07

2. CNS Neurotoxicity of Antiretrovirals;Journal of Neuroimmune Pharmacology;2019-12-10

3. Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1);Pharmaceutical Research;2018-01

4. Neuropharmacology;Handbook of Clinical Neurology;2018

5. Antiretroviral Therapy: Brain Penetration;Global Virology II - HIV and NeuroAIDS;2017